Project Grant HT94252510217
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The federal Project Grant award of $472,498.00, issued by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), is supporting research at The Ohio State University to target the UPP1-mediated pyrimidine salvage pathway in order to prevent ovarian cancer recurrence. The research project, set to run from November 1, 2024 to October 31, 2026, aims to develop innovative approaches to disease prevention, diagnosis, treatment, and...
This federal Project Grant award of $1,317,976 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research at The Ohio State University to target the RAL G proteins to treat triple-negative breast cancer. The award, with a performance period from July 1, 2025 to June 30, 2028, will fund innovative biomedical research aimed at transforming healthcare for military service members and the general public. The research...
This $630,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports The Ohio State University's research to develop a targeted antibody and immunotoxin combination therapy to improve treatment of T-cell lymphoma. The award period is from July 15, 2023 to July 14, 2025. This research aims to transform health care for Service Members and the American public through innovative and impactful medical solutions for the...
The Department of the Army Medical Command awarded a $472,500 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The Ohio State University to explore the role of CHD1L expression as an early event in high-grade serous ovarian cancer. This 2-year research project, with a performance period from June 1, 2024 to May 31, 2026, aims to advance the understanding of this form of ovarian cancer to support the development of improved diagnostic tools and treatments for military...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
This federal Project Grant award of $1,251,451 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) aims to support research on metastatic progression in medullary thyroid cancer. The award period runs from July 1, 2023 to June 30, 2027 and will be carried out by the prime awardee, The Ohio State University (OSU). Under the grant, OSU will conduct genomic sequencing studies and organoid/metastasis-on-a-chip studies to investigate...
The federal Project Grant award, valued at $1,225,245.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" research conducted by The Ohio State University. The research will focus on investigating innovative approaches to disease prevention, diagnosis, treatment, and management of conditions relevant...
The Ohio State University received a $156,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The two-year award beginning in June 2021 will support research on Fatty Acid Binding Protein-5 as a novel therapeutic target against aggressive lung cancer. Through this funding, The Ohio State University researchers will investigate medical solutions for lung cancer, advancing the Military Medical Research...
The Department of the Army Medical Command awarded a $708,750 Project Grant to The Ohio State University Office of Sponsored Programs under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2025 to identify novel biomarkers for early detection of ovarian cancer using exosomes. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving military and...
This federal Project Grant award of $157,500.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research by The Ohio State University to explore PHOSPHOLIPASE C GAMMA 2 (PLCG2) as a potential therapeutic target against metastatic small cell lung cancer. The award has a performance period from June 1, 2024 to May 31, 2025. As a public research university with extensive experience executing federal research grants, The Ohio...